{"changeSha256":"01a533861e107d9fb1059d8a620080fcc52f4fb9dff209eb832c7e012b5cd2a4","changedAt":"2026-07-29","changedFields":[{"after":"A research peptide represented by FDA compounding-review material and one selected trial-registry record.","before":"A research peptide with FDA compounding records and a recent trial-registry entry.","field":"Profile summary"},{"after":"FDA presented BPC-157 briefing material at its July 2026 pharmacy-compounding advisory-committee meeting. Committee recommendations are nonbinding and FDA's final determination remains pending; the cited trial registration also does not establish safety or effectiveness.","before":"FDA's 2026 briefing says BPC-157 is not a component of an FDA-approved drug and describes limited safety information and characterization concerns. ClinicalTrials.gov also lists a recruiting study; registration is not proof of effectiveness.","field":"Evidence note"},{"after":"fda-bpc-157-briefing, fda-bulk-peptide-risks, ctg-nct07437547-v1, fda-pcac-peptide-meeting-2026","before":"fda-bpc-157-briefing, fda-bulk-peptide-risks, ctg-nct07437547-v1","field":"Cited source records"},{"after":"U.S. Food and Drug Administration [sources: fda-bpc-157-briefing, fda-pcac-peptide-meeting-2026]; Hudson Biotech [sources: ctg-nct07437547-v1]","before":"U.S. Food and Drug Administration [sources: fda-bpc-157-briefing]; Hudson Biotech [sources: ctg-nct07437547-v1]","field":"Named organizations"},{"after":"name: fda-bpc-157-briefing; aliases: fda-bpc-157-briefing; category: fda-bpc-157-briefing, fda-bulk-peptide-risks, fda-pcac-peptide-meeting-2026; status: fda-bpc-157-briefing; summary: fda-bpc-157-briefing, fda-pcac-peptide-meeting-2026, ctg-nct07437547-v1; evidenceNote: fda-bpc-157-briefing, fda-pcac-peptide-meeting-2026, ctg-nct07437547-v1","before":"name: fda-bpc-157-briefing; aliases: fda-bpc-157-briefing; category: fda-bpc-157-briefing, fda-bulk-peptide-risks; status: fda-bpc-157-briefing; summary: fda-bulk-peptide-risks, ctg-nct07437547-v1; evidenceNote: fda-bpc-157-briefing, ctg-nct07437547-v1","field":"Claim citations"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/bpc-157/versions/2/","version":2},"id":"profile:bpc-157:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-updated","notice":"We added the July 2026 FDA advisory-committee meeting context and clarified that both the committee process and the selected trial record have limited implications.","peptideSlugs":["bpc-157"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/bpc-157/versions/1/","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"fda-bpc-157-briefing","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"FDA briefing document for BPC-157-related bulk drug substances","url":"https://www.fda.gov/media/193343/download","verifiedAt":"2026-07-29"},{"id":"fda-pcac-peptide-meeting-2026","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"July 23-24, 2026 Pharmacy Compounding Advisory Committee meeting","url":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","verifiedAt":"2026-07-29"}],"subject":{"slug":"bpc-157","type":"profile"}}